Corrigendum to “Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer” [J. Control. Release 239 (2016) 39–48] (S0168365916305181) (10.1016/j.jconrel.2016.08.016)

Barbara Grünwald, Jennifer Vandooren, Erica Locatelli, Pierre Fiten, Ghislain Opdenakker, Paul Proost, Achim Krüger, Jean Paul Lellouche, Liron Limor Israel, Louis Shenkman, Mauro Comes Franchini*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to “Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer” [J. Control. Release 239 (2016) 39–48] (S0168365916305181) (10.1016/j.jconrel.2016.08.016)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry